| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 360 | 2024 | 3246 | 23.710 |
Why?
|
| Pulmonary Emphysema | 83 | 2024 | 683 | 7.980 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 34 | 2024 | 113 | 4.970 |
Why?
|
| Emphysema | 27 | 2024 | 234 | 4.540 |
Why?
|
| Forced Expiratory Volume | 122 | 2024 | 1828 | 4.480 |
Why?
|
| Genetic Predisposition to Disease | 168 | 2024 | 18075 | 4.260 |
Why?
|
| Lung | 135 | 2024 | 10067 | 3.940 |
Why?
|
| alpha 1-Antitrypsin | 25 | 2024 | 168 | 3.820 |
Why?
|
| Genome-Wide Association Study | 144 | 2024 | 12806 | 3.810 |
Why?
|
| Smoking | 155 | 2024 | 9077 | 3.700 |
Why?
|
| Polymorphism, Single Nucleotide | 151 | 2024 | 16044 | 3.370 |
Why?
|
| Spirometry | 70 | 2024 | 929 | 3.020 |
Why?
|
| Asthma | 81 | 2023 | 6268 | 1.850 |
Why?
|
| Genetic Loci | 24 | 2023 | 2630 | 1.830 |
Why?
|
| Genetic Linkage | 27 | 2019 | 2342 | 1.790 |
Why?
|
| Vital Capacity | 42 | 2024 | 995 | 1.760 |
Why?
|
| Phenotype | 126 | 2024 | 16724 | 1.720 |
Why?
|
| Respiratory Function Tests | 53 | 2024 | 1691 | 1.700 |
Why?
|
| GTPase-Activating Proteins | 10 | 2021 | 465 | 1.620 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 13 | 2024 | 520 | 1.560 |
Why?
|
| Tomography, X-Ray Computed | 97 | 2024 | 20708 | 1.550 |
Why?
|
| Transforming Growth Factor beta2 | 3 | 2021 | 71 | 1.520 |
Why?
|
| Lung Diseases, Interstitial | 14 | 2024 | 939 | 1.480 |
Why?
|
| Disease Progression | 48 | 2024 | 13640 | 1.470 |
Why?
|
| Genotype | 81 | 2023 | 13036 | 1.210 |
Why?
|
| Bronchitis, Chronic | 10 | 2022 | 81 | 1.190 |
Why?
|
| Receptors, Nicotinic | 8 | 2019 | 494 | 1.160 |
Why?
|
| Gene Regulatory Networks | 13 | 2024 | 1751 | 1.160 |
Why?
|
| Humans | 600 | 2024 | 766766 | 1.160 |
Why?
|
| Iron Regulatory Protein 2 | 8 | 2016 | 43 | 1.130 |
Why?
|
| Bronchodilator Agents | 19 | 2022 | 513 | 1.120 |
Why?
|
| Middle Aged | 305 | 2024 | 223257 | 1.110 |
Why?
|
| Genome, Human | 28 | 2024 | 4443 | 1.080 |
Why?
|
| Models, Genetic | 29 | 2022 | 3450 | 1.040 |
Why?
|
| Case-Control Studies | 77 | 2024 | 22248 | 1.030 |
Why?
|
| Epoxide Hydrolases | 6 | 2010 | 122 | 1.030 |
Why?
|
| Severity of Illness Index | 75 | 2024 | 15908 | 1.020 |
Why?
|
| Polymorphism, Genetic | 29 | 2017 | 4249 | 1.000 |
Why?
|
| Male | 371 | 2024 | 364142 | 0.990 |
Why?
|
| Lung Diseases, Obstructive | 11 | 2008 | 309 | 0.980 |
Why?
|
| Aged | 239 | 2024 | 171343 | 0.970 |
Why?
|
| Female | 378 | 2024 | 396520 | 0.950 |
Why?
|
| Computational Biology | 14 | 2024 | 3564 | 0.900 |
Why?
|
| Pulmonary Artery | 9 | 2024 | 1938 | 0.890 |
Why?
|
| Genetic Association Studies | 18 | 2023 | 2746 | 0.880 |
Why?
|
| Genetic Variation | 34 | 2024 | 6612 | 0.860 |
Why?
|
| Cachexia | 3 | 2020 | 202 | 0.850 |
Why?
|
| Adaptor Protein Complex delta Subunits | 1 | 2021 | 3 | 0.790 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2021 | 17 | 0.780 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 5 | 2008 | 44 | 0.780 |
Why?
|
| Amyloid beta-Protein Precursor | 7 | 2010 | 1117 | 0.770 |
Why?
|
| Membrane Glycoproteins | 13 | 2021 | 3702 | 0.760 |
Why?
|
| Lupus Erythematosus, Systemic | 16 | 2013 | 2160 | 0.740 |
Why?
|
| Linkage Disequilibrium | 29 | 2021 | 1996 | 0.720 |
Why?
|
| Carrier Proteins | 13 | 2021 | 4924 | 0.710 |
Why?
|
| Receptors, Cell Surface | 12 | 2010 | 2815 | 0.710 |
Why?
|
| Haplotypes | 25 | 2024 | 2727 | 0.690 |
Why?
|
| Genetic Markers | 18 | 2022 | 2603 | 0.670 |
Why?
|
| Lung Diseases | 10 | 2024 | 1941 | 0.660 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2019 | 56 | 0.650 |
Why?
|
| Risk Factors | 100 | 2024 | 74881 | 0.650 |
Why?
|
| Body Mass Index | 15 | 2024 | 13050 | 0.630 |
Why?
|
| Longitudinal Studies | 49 | 2024 | 14762 | 0.610 |
Why?
|
| Quantitative Trait Loci | 20 | 2024 | 2136 | 0.610 |
Why?
|
| DNA | 11 | 2020 | 7208 | 0.610 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 5 | 2018 | 49 | 0.590 |
Why?
|
| Dyspnea | 12 | 2024 | 1352 | 0.590 |
Why?
|
| Gene Frequency | 33 | 2024 | 3624 | 0.590 |
Why?
|
| Glutathione S-Transferase pi | 3 | 2016 | 99 | 0.590 |
Why?
|
| Heterozygote | 13 | 2022 | 2795 | 0.590 |
Why?
|
| Genomics | 17 | 2024 | 5923 | 0.570 |
Why?
|
| Immunoglobulin E | 18 | 2021 | 1495 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 4 | 8 | 2024 | 378 | 0.570 |
Why?
|
| Bronchiectasis | 4 | 2023 | 141 | 0.570 |
Why?
|
| Albuterol | 6 | 2014 | 211 | 0.560 |
Why?
|
| Pedigree | 20 | 2024 | 4539 | 0.560 |
Why?
|
| Social Work | 1 | 2018 | 158 | 0.560 |
Why?
|
| Systems Biology | 4 | 2020 | 481 | 0.550 |
Why?
|
| Gene Expression | 13 | 2020 | 7585 | 0.550 |
Why?
|
| Serpin E2 | 8 | 2020 | 48 | 0.540 |
Why?
|
| Cohort Studies | 78 | 2024 | 41710 | 0.540 |
Why?
|
| Respiration | 2 | 2017 | 1654 | 0.540 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2017 | 163 | 0.520 |
Why?
|
| Proteome | 3 | 2024 | 1894 | 0.510 |
Why?
|
| Databases, Genetic | 6 | 2019 | 1756 | 0.510 |
Why?
|
| Desmoplakins | 4 | 2022 | 63 | 0.500 |
Why?
|
| Maximal Midexpiratory Flow Rate | 3 | 2004 | 75 | 0.490 |
Why?
|
| Aged, 80 and over | 75 | 2024 | 59550 | 0.480 |
Why?
|
| Models, Organizational | 1 | 2018 | 548 | 0.480 |
Why?
|
| Proteomics | 8 | 2024 | 3914 | 0.480 |
Why?
|
| Mass Spectrometry | 2 | 2021 | 2198 | 0.470 |
Why?
|
| Adult | 138 | 2024 | 223307 | 0.470 |
Why?
|
| Alleles | 23 | 2023 | 6895 | 0.460 |
Why?
|
| Airway Obstruction | 5 | 2024 | 672 | 0.450 |
Why?
|
| Empathy | 1 | 2018 | 474 | 0.450 |
Why?
|
| Gene Expression Regulation | 19 | 2024 | 11920 | 0.440 |
Why?
|
| Bronchi | 5 | 2022 | 847 | 0.440 |
Why?
|
| Exercise Tolerance | 10 | 2015 | 847 | 0.440 |
Why?
|
| Rare Diseases | 1 | 2019 | 630 | 0.430 |
Why?
|
| DNA Methylation | 11 | 2024 | 4427 | 0.430 |
Why?
|
| Gene Expression Profiling | 18 | 2024 | 9525 | 0.420 |
Why?
|
| Inflammation | 12 | 2024 | 10860 | 0.420 |
Why?
|
| Protease Nexins | 7 | 2010 | 39 | 0.420 |
Why?
|
| Total Lung Capacity | 8 | 2020 | 148 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 14 | 2023 | 5789 | 0.410 |
Why?
|
| Elastin | 3 | 2010 | 299 | 0.410 |
Why?
|
| Age of Onset | 15 | 2018 | 3342 | 0.410 |
Why?
|
| Risk Assessment | 24 | 2024 | 24295 | 0.400 |
Why?
|
| Genome | 5 | 2024 | 1752 | 0.400 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 7 | 2022 | 325 | 0.400 |
Why?
|
| Disease | 2 | 2020 | 675 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2019 | 451 | 0.390 |
Why?
|
| Cluster Analysis | 13 | 2023 | 2717 | 0.380 |
Why?
|
| Computer Simulation | 20 | 2022 | 6259 | 0.380 |
Why?
|
| Chromosome Mapping | 14 | 2015 | 4619 | 0.380 |
Why?
|
| Serine Proteinase Inhibitors | 4 | 2011 | 174 | 0.370 |
Why?
|
| Information Services | 1 | 2012 | 239 | 0.370 |
Why?
|
| Respiratory System Abnormalities | 2 | 2022 | 67 | 0.370 |
Why?
|
| Epithelial Cells | 5 | 2020 | 3691 | 0.370 |
Why?
|
| Nerve Tissue Proteins | 9 | 2021 | 4400 | 0.370 |
Why?
|
| Tobacco Smoke Pollution | 7 | 2013 | 828 | 0.360 |
Why?
|
| Family | 14 | 2017 | 3209 | 0.360 |
Why?
|
| Logistic Models | 27 | 2021 | 13278 | 0.350 |
Why?
|
| Community Networks | 1 | 2012 | 202 | 0.350 |
Why?
|
| Receptors, Adrenergic, beta-2 | 5 | 2004 | 216 | 0.350 |
Why?
|
| Mosaicism | 2 | 2024 | 480 | 0.350 |
Why?
|
| Mucin-5B | 6 | 2023 | 148 | 0.350 |
Why?
|
| Pulmonary Medicine | 2 | 2015 | 223 | 0.340 |
Why?
|
| Pulmonary Fibrosis | 6 | 2021 | 505 | 0.340 |
Why?
|
| Epigenomics | 6 | 2024 | 959 | 0.340 |
Why?
|
| Genetics, Population | 6 | 2024 | 943 | 0.330 |
Why?
|
| beta-Defensins | 2 | 2006 | 59 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2006 | 432 | 0.330 |
Why?
|
| Genetic Techniques | 1 | 2012 | 428 | 0.330 |
Why?
|
| Airway Resistance | 2 | 2013 | 407 | 0.330 |
Why?
|
| Algorithms | 22 | 2024 | 14072 | 0.320 |
Why?
|
| Tandem Repeat Sequences | 3 | 2005 | 184 | 0.320 |
Why?
|
| Consensus | 1 | 2019 | 3208 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.320 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 957 | 0.320 |
Why?
|
| Predictive Value of Tests | 21 | 2022 | 15416 | 0.310 |
Why?
|
| Software | 12 | 2024 | 4466 | 0.310 |
Why?
|
| Norway | 9 | 2015 | 500 | 0.310 |
Why?
|
| Republic of Korea | 6 | 2024 | 591 | 0.310 |
Why?
|
| Cardiovascular Diseases | 8 | 2024 | 15657 | 0.310 |
Why?
|
| Prospective Studies | 34 | 2024 | 54871 | 0.310 |
Why?
|
| Sputum | 5 | 2023 | 514 | 0.300 |
Why?
|
| Follow-Up Studies | 34 | 2024 | 39309 | 0.300 |
Why?
|
| Quality of Life | 22 | 2023 | 13476 | 0.300 |
Why?
|
| Exons | 8 | 2023 | 2392 | 0.290 |
Why?
|
| Williams Syndrome | 1 | 2010 | 195 | 0.290 |
Why?
|
| Interleukin-10 | 5 | 2009 | 1182 | 0.290 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 2011 | 93 | 0.290 |
Why?
|
| Receptors, Immunologic | 4 | 2024 | 1418 | 0.290 |
Why?
|
| Sequence Analysis, RNA | 6 | 2024 | 2039 | 0.280 |
Why?
|
| Sex Characteristics | 6 | 2014 | 2645 | 0.280 |
Why?
|
| Macrophages, Alveolar | 2 | 2020 | 413 | 0.280 |
Why?
|
| Prognosis | 27 | 2024 | 29948 | 0.280 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2024 | 3788 | 0.270 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2006 | 52 | 0.270 |
Why?
|
| Respiratory Physiological Phenomena | 4 | 2023 | 191 | 0.270 |
Why?
|
| DNA Helicases | 2 | 2019 | 853 | 0.260 |
Why?
|
| Serpins | 2 | 2015 | 245 | 0.260 |
Why?
|
| Germ-Line Mutation | 4 | 2023 | 1885 | 0.260 |
Why?
|
| Radiography, Thoracic | 8 | 2015 | 1320 | 0.260 |
Why?
|
| Cross-Sectional Studies | 34 | 2024 | 26310 | 0.260 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2014 | 1363 | 0.260 |
Why?
|
| Bronchitis | 4 | 2017 | 193 | 0.260 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 6 | 2010 | 1226 | 0.260 |
Why?
|
| Multivariate Analysis | 20 | 2019 | 12064 | 0.250 |
Why?
|
| Fibrinogen | 4 | 2024 | 893 | 0.250 |
Why?
|
| Pectoralis Muscles | 2 | 2018 | 86 | 0.250 |
Why?
|
| Respiratory Tract Diseases | 3 | 2024 | 744 | 0.250 |
Why?
|
| Quantitative Trait, Heritable | 4 | 2006 | 541 | 0.250 |
Why?
|
| Chemokines, CC | 3 | 2014 | 285 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2015 | 386 | 0.250 |
Why?
|
| RNA, Untranslated | 2 | 2020 | 455 | 0.250 |
Why?
|
| Sequence Analysis, DNA | 7 | 2019 | 4780 | 0.240 |
Why?
|
| Comorbidity | 16 | 2022 | 10580 | 0.240 |
Why?
|
| Lupus Erythematosus, Cutaneous | 2 | 2010 | 75 | 0.240 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2019 | 637 | 0.240 |
Why?
|
| Pulmonary Ventilation | 4 | 2013 | 375 | 0.240 |
Why?
|
| Lod Score | 6 | 2009 | 600 | 0.240 |
Why?
|
| United States | 47 | 2024 | 72951 | 0.240 |
Why?
|
| Prevalence | 19 | 2024 | 15835 | 0.240 |
Why?
|
| Child | 66 | 2024 | 80668 | 0.240 |
Why?
|
| Poland | 2 | 2017 | 197 | 0.240 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2010 | 587 | 0.240 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2019 | 572 | 0.240 |
Why?
|
| Environmental Exposure | 3 | 2019 | 4554 | 0.240 |
Why?
|
| Curriculum | 1 | 2018 | 3783 | 0.240 |
Why?
|
| Pneumonectomy | 3 | 2009 | 1147 | 0.240 |
Why?
|
| Respiratory Mechanics | 4 | 2013 | 719 | 0.230 |
Why?
|
| Dermatitis, Atopic | 3 | 2021 | 734 | 0.230 |
Why?
|
| Drug Discovery | 1 | 2012 | 1065 | 0.230 |
Why?
|
| Heart Block | 2 | 2000 | 391 | 0.230 |
Why?
|
| Lymphangioleiomyomatosis | 2 | 2019 | 206 | 0.230 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2022 | 836 | 0.230 |
Why?
|
| Membrane Proteins | 7 | 2024 | 7868 | 0.220 |
Why?
|
| Medicine | 1 | 2012 | 944 | 0.220 |
Why?
|
| Telomere | 4 | 2024 | 943 | 0.220 |
Why?
|
| Epigenesis, Genetic | 9 | 2024 | 3824 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2024 | 2885 | 0.220 |
Why?
|
| Linear Models | 14 | 2024 | 5874 | 0.220 |
Why?
|
| Family Health | 7 | 2009 | 1254 | 0.220 |
Why?
|
| Sex Factors | 13 | 2021 | 10619 | 0.220 |
Why?
|
| Disease Models, Animal | 11 | 2021 | 18330 | 0.210 |
Why?
|
| Genetic Testing | 7 | 2021 | 3591 | 0.210 |
Why?
|
| Respiratory Mucosa | 2 | 2019 | 437 | 0.210 |
Why?
|
| Reproducibility of Results | 19 | 2024 | 20144 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 3 | 2006 | 1996 | 0.210 |
Why?
|
| Nuclear Family | 5 | 2011 | 311 | 0.200 |
Why?
|
| Regression Analysis | 11 | 2022 | 6329 | 0.200 |
Why?
|
| Models, Statistical | 8 | 2021 | 5091 | 0.200 |
Why?
|
| Uteroglobin | 3 | 2012 | 55 | 0.200 |
Why?
|
| Transplantation Chimera | 1 | 2005 | 609 | 0.200 |
Why?
|
| Respiratory Insufficiency | 2 | 2024 | 1241 | 0.200 |
Why?
|
| Nedocromil | 2 | 2019 | 45 | 0.200 |
Why?
|
| Odds Ratio | 11 | 2022 | 9661 | 0.200 |
Why?
|
| Immunity, Innate | 5 | 2024 | 3077 | 0.200 |
Why?
|
| RNA Splice Sites | 1 | 2023 | 212 | 0.200 |
Why?
|
| Cause of Death | 5 | 2024 | 3716 | 0.200 |
Why?
|
| Molecular Epidemiology | 3 | 2019 | 473 | 0.200 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2020 | 3666 | 0.200 |
Why?
|
| Internationality | 4 | 2020 | 1006 | 0.200 |
Why?
|
| Somatomedins | 1 | 2022 | 179 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 3 | 2015 | 1604 | 0.200 |
Why?
|
| Respiratory System | 4 | 2016 | 562 | 0.190 |
Why?
|
| Mortality | 3 | 2024 | 2910 | 0.190 |
Why?
|
| Bronchography | 2 | 2013 | 74 | 0.190 |
Why?
|
| Chromosomes, Human | 2 | 2013 | 437 | 0.190 |
Why?
|
| Animals | 40 | 2024 | 168930 | 0.190 |
Why?
|
| Leukocytes | 2 | 2021 | 2035 | 0.190 |
Why?
|
| Autophagy | 2 | 2024 | 1346 | 0.190 |
Why?
|
| Activin Receptors, Type I | 2 | 2019 | 133 | 0.190 |
Why?
|
| Environment | 4 | 2019 | 1120 | 0.190 |
Why?
|
| Data Interpretation, Statistical | 8 | 2021 | 2693 | 0.190 |
Why?
|
| Protein Interaction Mapping | 2 | 2023 | 621 | 0.180 |
Why?
|
| Budesonide | 2 | 2019 | 162 | 0.180 |
Why?
|
| HLA-A2 Antigen | 1 | 2021 | 207 | 0.180 |
Why?
|
| Mitochondria, Liver | 1 | 2021 | 190 | 0.180 |
Why?
|
| Memory Disorders | 1 | 2008 | 1193 | 0.180 |
Why?
|
| ADAM Proteins | 3 | 2020 | 243 | 0.180 |
Why?
|
| Acetyltransferases | 1 | 2021 | 230 | 0.180 |
Why?
|
| Polycythemia | 1 | 2021 | 124 | 0.170 |
Why?
|
| Bayes Theorem | 6 | 2021 | 2354 | 0.170 |
Why?
|
| Lymphocytes | 2 | 2021 | 2605 | 0.170 |
Why?
|
| Mucins | 1 | 2023 | 569 | 0.170 |
Why?
|
| Tomography, Emission-Computed | 1 | 2022 | 1006 | 0.170 |
Why?
|
| Response Elements | 1 | 2021 | 308 | 0.170 |
Why?
|
| Mucus | 3 | 2023 | 346 | 0.170 |
Why?
|
| Models, Biological | 6 | 2017 | 9461 | 0.170 |
Why?
|
| Multifactorial Inheritance | 3 | 2024 | 1425 | 0.170 |
Why?
|
| C-Reactive Protein | 6 | 2012 | 3853 | 0.170 |
Why?
|
| Airway Remodeling | 6 | 2017 | 134 | 0.160 |
Why?
|
| COUP Transcription Factor II | 1 | 2019 | 19 | 0.160 |
Why?
|
| Chromatin | 2 | 2021 | 2977 | 0.160 |
Why?
|
| Birds | 1 | 2000 | 165 | 0.160 |
Why?
|
| Hyperostosis, Diffuse Idiopathic Skeletal | 1 | 2019 | 23 | 0.160 |
Why?
|
| Hyperostosis | 1 | 2019 | 29 | 0.160 |
Why?
|
| Cell Line | 5 | 2021 | 15563 | 0.160 |
Why?
|
| Women | 1 | 2001 | 225 | 0.160 |
Why?
|
| Mutation | 16 | 2024 | 30213 | 0.160 |
Why?
|
| beta-Globins | 1 | 2019 | 111 | 0.160 |
Why?
|
| Alternative Splicing | 3 | 2023 | 1103 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2020 | 370 | 0.160 |
Why?
|
| Haemophilus influenzae | 1 | 2019 | 177 | 0.160 |
Why?
|
| Nitric Oxide Synthase | 3 | 2013 | 911 | 0.160 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2007 | 348 | 0.160 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2019 | 78 | 0.160 |
Why?
|
| Bronchoconstriction | 1 | 1999 | 141 | 0.160 |
Why?
|
| Incidence | 16 | 2024 | 21525 | 0.160 |
Why?
|
| Phagocytosis | 1 | 2024 | 1527 | 0.160 |
Why?
|
| Lung Transplantation | 2 | 2024 | 1310 | 0.160 |
Why?
|
| Oxyhemoglobins | 1 | 2019 | 213 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2023 | 903 | 0.160 |
Why?
|
| Mice | 22 | 2024 | 81889 | 0.150 |
Why?
|
| Oxygen | 4 | 2023 | 4251 | 0.150 |
Why?
|
| Adolescent | 40 | 2024 | 88904 | 0.150 |
Why?
|
| Chromosome Deletion | 2 | 2015 | 1384 | 0.150 |
Why?
|
| Hospitals, Psychiatric | 1 | 2000 | 318 | 0.150 |
Why?
|
| Telomerase | 3 | 2024 | 750 | 0.150 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 1998 | 128 | 0.150 |
Why?
|
| Body Height | 1 | 2024 | 1562 | 0.150 |
Why?
|
| Cough | 5 | 2019 | 599 | 0.150 |
Why?
|
| Heme | 1 | 2020 | 316 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2019 | 2801 | 0.150 |
Why?
|
| Pattern Recognition, Automated | 3 | 2010 | 979 | 0.150 |
Why?
|
| Fibroblasts | 3 | 2021 | 4166 | 0.150 |
Why?
|
| Gastroesophageal Reflux | 2 | 2014 | 834 | 0.150 |
Why?
|
| Homozygote | 2 | 2016 | 1775 | 0.140 |
Why?
|
| Costa Rica | 9 | 2011 | 187 | 0.140 |
Why?
|
| Interleukin-13 | 3 | 2007 | 391 | 0.140 |
Why?
|
| F-Box Proteins | 1 | 2019 | 199 | 0.140 |
Why?
|
| Programming Languages | 1 | 2018 | 133 | 0.140 |
Why?
|
| Chi-Square Distribution | 6 | 2017 | 3432 | 0.140 |
Why?
|
| Genetic Pleiotropy | 1 | 2019 | 182 | 0.140 |
Why?
|
| Chromosome Aberrations | 1 | 2024 | 1776 | 0.140 |
Why?
|
| CpG Islands | 5 | 2021 | 1208 | 0.140 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 228 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2011 | 350 | 0.140 |
Why?
|
| Leukotrienes | 1 | 1998 | 232 | 0.140 |
Why?
|
| Pharmacogenetics | 4 | 2007 | 682 | 0.140 |
Why?
|
| Cognition Disorders | 2 | 2008 | 3967 | 0.140 |
Why?
|
| Hemizygote | 1 | 2016 | 27 | 0.140 |
Why?
|
| Exosomes | 1 | 2021 | 417 | 0.140 |
Why?
|
| Hematopoiesis | 2 | 2023 | 2060 | 0.140 |
Why?
|
| Osteoarthropathy, Secondary Hypertrophic | 1 | 1996 | 13 | 0.140 |
Why?
|
| Health Status | 7 | 2016 | 4087 | 0.140 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 792 | 0.130 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2023 | 617 | 0.130 |
Why?
|
| Multigene Family | 2 | 2013 | 1081 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2024 | 3408 | 0.130 |
Why?
|
| Walking | 6 | 2014 | 1201 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2023 | 3792 | 0.130 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2021 | 418 | 0.130 |
Why?
|
| Protein Transport | 1 | 2021 | 1942 | 0.130 |
Why?
|
| Forecasting | 3 | 2022 | 2936 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2015 | 361 | 0.130 |
Why?
|
| Mothers | 2 | 2011 | 2208 | 0.130 |
Why?
|
| Genes, X-Linked | 1 | 2016 | 129 | 0.130 |
Why?
|
| Eosinophils | 3 | 2018 | 952 | 0.130 |
Why?
|
| Nose | 1 | 2019 | 522 | 0.130 |
Why?
|
| Iron-Binding Proteins | 1 | 2016 | 83 | 0.130 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2017 | 227 | 0.130 |
Why?
|
| Placebo Effect | 1 | 2019 | 515 | 0.120 |
Why?
|
| Models, Psychological | 1 | 2000 | 823 | 0.120 |
Why?
|
| Young Adult | 16 | 2024 | 59939 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2016 | 322 | 0.120 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2016 | 294 | 0.120 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2021 | 1044 | 0.120 |
Why?
|
| Hernia, Hiatal | 1 | 1996 | 90 | 0.120 |
Why?
|
| Smoking Cessation | 5 | 2020 | 2085 | 0.120 |
Why?
|
| Galactosylceramidase | 1 | 2015 | 22 | 0.120 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 633 | 0.120 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2019 | 246 | 0.120 |
Why?
|
| Klinefelter Syndrome | 1 | 2015 | 48 | 0.120 |
Why?
|
| Population | 1 | 2015 | 140 | 0.120 |
Why?
|
| Hypoprothrombinemias | 1 | 1994 | 1 | 0.120 |
Why?
|
| Iron Chelating Agents | 1 | 2016 | 141 | 0.120 |
Why?
|
| Mexican Americans | 3 | 2004 | 165 | 0.120 |
Why?
|
| Axonemal Dyneins | 1 | 2014 | 25 | 0.120 |
Why?
|
| Ovary | 1 | 1999 | 963 | 0.120 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2019 | 366 | 0.120 |
Why?
|
| Autoantibodies | 3 | 2000 | 2115 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2000 | 535 | 0.120 |
Why?
|
| Retrospective Studies | 19 | 2022 | 81635 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 334 | 0.110 |
Why?
|
| Pneumothorax | 2 | 2014 | 393 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2018 | 4047 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 5 | 2016 | 1733 | 0.110 |
Why?
|
| Boston | 6 | 2020 | 9346 | 0.110 |
Why?
|
| Smoke | 1 | 2016 | 243 | 0.110 |
Why?
|
| Sensitivity and Specificity | 14 | 2013 | 14652 | 0.110 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 48 | 0.110 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2014 | 109 | 0.110 |
Why?
|
| Base Sequence | 9 | 2019 | 12415 | 0.110 |
Why?
|
| Antirheumatic Agents | 1 | 2023 | 1383 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2012 | 4349 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3796 | 0.110 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2013 | 32 | 0.110 |
Why?
|
| Chemokines | 1 | 2017 | 962 | 0.110 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2013 | 39 | 0.110 |
Why?
|
| Manikins | 1 | 2015 | 255 | 0.110 |
Why?
|
| Blood Cells | 1 | 2015 | 308 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2024 | 23619 | 0.110 |
Why?
|
| Medical History Taking | 1 | 2017 | 779 | 0.100 |
Why?
|
| Pneumonia | 3 | 2017 | 2159 | 0.100 |
Why?
|
| Radiology | 1 | 2007 | 2105 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1161 | 0.100 |
Why?
|
| Movement | 1 | 2000 | 1468 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 734 | 0.100 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Antigens, CD | 2 | 2016 | 4032 | 0.100 |
Why?
|
| DNA-Binding Proteins | 6 | 2020 | 9611 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 4 | 2013 | 873 | 0.100 |
Why?
|
| Soft Tissue Infections | 1 | 2014 | 166 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2023 | 1595 | 0.100 |
Why?
|
| Traction | 2 | 2023 | 112 | 0.100 |
Why?
|
| Ankyrins | 1 | 2012 | 123 | 0.100 |
Why?
|
| Body Composition | 4 | 2017 | 2441 | 0.100 |
Why?
|
| Hospitalization | 6 | 2014 | 10823 | 0.100 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2005 | 299 | 0.100 |
Why?
|
| Europe | 3 | 2019 | 3430 | 0.100 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2012 | 345 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2017 | 8926 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4276 | 0.100 |
Why?
|
| Lung Neoplasms | 5 | 2024 | 13485 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2001 | 2021 | 0.100 |
Why?
|
| Sp3 Transcription Factor | 1 | 2011 | 30 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 1217 | 0.100 |
Why?
|
| Cadherins | 1 | 2017 | 902 | 0.100 |
Why?
|
| Rett Syndrome | 1 | 1994 | 164 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 2678 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2012 | 166 | 0.100 |
Why?
|
| Occupational Exposure | 4 | 2014 | 1807 | 0.100 |
Why?
|
| Metalloendopeptidases | 2 | 2004 | 386 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2000 | 1865 | 0.100 |
Why?
|
| Cells, Cultured | 7 | 2021 | 18984 | 0.100 |
Why?
|
| Chromosome Disorders | 1 | 2014 | 498 | 0.100 |
Why?
|
| Artificial Intelligence | 2 | 2022 | 2662 | 0.100 |
Why?
|
| Survival Analysis | 6 | 2022 | 10100 | 0.100 |
Why?
|
| Cytokines | 4 | 2017 | 7438 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2016 | 1805 | 0.090 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2011 | 74 | 0.090 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2011 | 59 | 0.090 |
Why?
|
| Lead | 3 | 2007 | 879 | 0.090 |
Why?
|
| Interleukin-6 | 4 | 2024 | 3227 | 0.090 |
Why?
|
| Liver Diseases | 2 | 2010 | 1303 | 0.090 |
Why?
|
| Weight Loss | 2 | 2021 | 2712 | 0.090 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 1991 | 17 | 0.090 |
Why?
|
| beta Catenin | 1 | 2016 | 1048 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 2881 | 0.090 |
Why?
|
| SOXD Transcription Factors | 1 | 2011 | 44 | 0.090 |
Why?
|
| Sarcopenia | 1 | 2016 | 378 | 0.090 |
Why?
|
| Metabolomics | 3 | 2019 | 1675 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2016 | 1194 | 0.090 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2010 | 10 | 0.090 |
Why?
|
| Clinical Competence | 2 | 2018 | 4858 | 0.090 |
Why?
|
| Obesity | 4 | 2022 | 13090 | 0.090 |
Why?
|
| Administration, Inhalation | 5 | 2016 | 1154 | 0.090 |
Why?
|
| Superoxide Dismutase | 2 | 2010 | 595 | 0.090 |
Why?
|
| Suicide, Attempted | 1 | 2000 | 1413 | 0.090 |
Why?
|
| Exercise Test | 3 | 2014 | 2188 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 1466 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 526 | 0.090 |
Why?
|
| Leukocyte Count | 4 | 2018 | 1606 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1882 | 0.090 |
Why?
|
| Principal Component Analysis | 3 | 2023 | 949 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 2 | 2019 | 1325 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2448 | 0.090 |
Why?
|
| DNA Copy Number Variations | 2 | 2016 | 2045 | 0.090 |
Why?
|
| Mammography | 1 | 2001 | 2429 | 0.090 |
Why?
|
| Respiratory Sounds | 3 | 2019 | 702 | 0.090 |
Why?
|
| Aging | 3 | 2021 | 8731 | 0.090 |
Why?
|
| Microarray Analysis | 3 | 2009 | 751 | 0.090 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 1730 | 0.090 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2009 | 44 | 0.090 |
Why?
|
| Sirtuin 2 | 1 | 2010 | 93 | 0.080 |
Why?
|
| Nutrition Surveys | 3 | 2024 | 1737 | 0.080 |
Why?
|
| Research Design | 6 | 2020 | 6207 | 0.080 |
Why?
|
| Densitometry | 1 | 2010 | 150 | 0.080 |
Why?
|
| Heptanoic Acids | 1 | 2012 | 344 | 0.080 |
Why?
|
| Tobacco Use Disorder | 2 | 2017 | 708 | 0.080 |
Why?
|
| Microsatellite Repeats | 3 | 2006 | 784 | 0.080 |
Why?
|
| Allergens | 4 | 2007 | 1436 | 0.080 |
Why?
|
| Aortic Diseases | 2 | 2010 | 741 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2015 | 1241 | 0.080 |
Why?
|
| Radiography | 6 | 2016 | 6968 | 0.080 |
Why?
|
| Cilia | 1 | 2013 | 498 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2014 | 968 | 0.080 |
Why?
|
| Transcription Factors | 5 | 2022 | 12150 | 0.080 |
Why?
|
| Health Policy | 2 | 2020 | 2698 | 0.080 |
Why?
|
| Tuberculosis | 1 | 2022 | 2011 | 0.080 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 42 | 0.080 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2010 | 129 | 0.080 |
Why?
|
| Siblings | 3 | 2008 | 828 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2010 | 310 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 712 | 0.080 |
Why?
|
| Leadership | 1 | 2018 | 1394 | 0.080 |
Why?
|
| Transition Temperature | 1 | 2008 | 33 | 0.080 |
Why?
|
| RNA | 4 | 2023 | 2715 | 0.080 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 75 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 856 | 0.080 |
Why?
|
| Educational Status | 2 | 2015 | 2510 | 0.080 |
Why?
|
| Sick Leave | 1 | 2009 | 105 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 340 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2020 | 4142 | 0.080 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 1767 | 0.080 |
Why?
|
| Mitochondria | 2 | 2016 | 3677 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2010 | 350 | 0.080 |
Why?
|
| Iron | 2 | 2016 | 1812 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 833 | 0.080 |
Why?
|
| Penetrance | 2 | 2023 | 388 | 0.080 |
Why?
|
| Analysis of Variance | 7 | 2014 | 6214 | 0.080 |
Why?
|
| Integrin beta3 | 1 | 2009 | 120 | 0.080 |
Why?
|
| Coronary Artery Disease | 3 | 2019 | 6558 | 0.080 |
Why?
|
| Trachea | 2 | 2013 | 1094 | 0.080 |
Why?
|
| Statistics as Topic | 5 | 2015 | 2351 | 0.080 |
Why?
|
| Bacteria | 1 | 2019 | 2212 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2015 | 1885 | 0.080 |
Why?
|
| Spinal Fractures | 1 | 2015 | 702 | 0.080 |
Why?
|
| Osteoporosis | 2 | 2015 | 1581 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1604 | 0.080 |
Why?
|
| Sample Size | 2 | 2022 | 844 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 2010 | 447 | 0.080 |
Why?
|
| Adipose Tissue | 2 | 2017 | 3314 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 3 | 2014 | 273 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2000 | 2254 | 0.070 |
Why?
|
| Observer Variation | 3 | 2012 | 2614 | 0.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 705 | 0.070 |
Why?
|
| Phencyclidine | 1 | 1987 | 59 | 0.070 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 4 | 1999 | 538 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 6 | 2008 | 6066 | 0.070 |
Why?
|
| Infant | 6 | 2021 | 36461 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 2012 | 2158 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 304 | 0.070 |
Why?
|
| Ascaris lumbricoides | 1 | 2007 | 10 | 0.070 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1987 | 171 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 128 | 0.070 |
Why?
|
| Depression | 3 | 2018 | 8228 | 0.070 |
Why?
|
| TRPV Cation Channels | 1 | 2009 | 244 | 0.070 |
Why?
|
| Decision Making | 1 | 2001 | 3951 | 0.070 |
Why?
|
| Hypercapnia | 1 | 2008 | 259 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2021 | 1228 | 0.070 |
Why?
|
| Cleft Lip | 1 | 2012 | 512 | 0.070 |
Why?
|
| Quality Control | 2 | 2021 | 834 | 0.070 |
Why?
|
| Age Factors | 9 | 2018 | 18397 | 0.070 |
Why?
|
| Time Factors | 9 | 2024 | 40149 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 3359 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2012 | 621 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 12245 | 0.070 |
Why?
|
| Self Report | 2 | 2018 | 3771 | 0.070 |
Why?
|
| Cleft Palate | 1 | 2012 | 596 | 0.070 |
Why?
|
| Disease Susceptibility | 5 | 2017 | 1791 | 0.070 |
Why?
|
| Antiparkinson Agents | 1 | 1987 | 184 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 541 | 0.070 |
Why?
|
| North America | 1 | 2010 | 1287 | 0.070 |
Why?
|
| Autoantigens | 1 | 1991 | 886 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4652 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2010 | 502 | 0.070 |
Why?
|
| Bronchial Provocation Tests | 3 | 2003 | 215 | 0.070 |
Why?
|
| Coronary Disease | 2 | 2020 | 5915 | 0.070 |
Why?
|
| Child, Preschool | 13 | 2021 | 42577 | 0.070 |
Why?
|
| Proportional Hazards Models | 5 | 2024 | 12534 | 0.070 |
Why?
|
| Arteriosclerosis | 1 | 2010 | 1055 | 0.070 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2006 | 45 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 335 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2016 | 3804 | 0.060 |
Why?
|
| Estradiol | 1 | 2013 | 1947 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2009 | 806 | 0.060 |
Why?
|
| Patella | 1 | 2007 | 317 | 0.060 |
Why?
|
| Pyrroles | 1 | 2012 | 1121 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 1396 | 0.060 |
Why?
|
| Treatment Outcome | 12 | 2020 | 65273 | 0.060 |
Why?
|
| Glutathione Transferase | 2 | 2009 | 565 | 0.060 |
Why?
|
| Probability | 4 | 2019 | 2476 | 0.060 |
Why?
|
| Learning | 1 | 2015 | 1754 | 0.060 |
Why?
|
| Lymphotoxin-alpha | 1 | 2005 | 94 | 0.060 |
Why?
|
| Pancreas | 1 | 1992 | 1698 | 0.060 |
Why?
|
| Skin Tests | 5 | 2007 | 630 | 0.060 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 7609 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 1987 | 575 | 0.060 |
Why?
|
| Calcinosis | 1 | 2014 | 1480 | 0.060 |
Why?
|
| Rest | 3 | 2016 | 940 | 0.060 |
Why?
|
| Thinness | 2 | 2022 | 482 | 0.060 |
Why?
|
| ROC Curve | 3 | 2021 | 3620 | 0.060 |
Why?
|
| Markov Chains | 2 | 2021 | 974 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2016 | 993 | 0.060 |
Why?
|
| Japan | 2 | 2021 | 1417 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2014 | 1949 | 0.060 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 17608 | 0.060 |
Why?
|
| High Mobility Group Proteins | 1 | 2005 | 179 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4252 | 0.060 |
Why?
|
| Skin Aging | 1 | 2006 | 140 | 0.060 |
Why?
|
| Epoxy Compounds | 1 | 2005 | 137 | 0.060 |
Why?
|
| Veterans Disability Claims | 1 | 2024 | 24 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 165 | 0.060 |
Why?
|
| Aorta | 1 | 2012 | 2043 | 0.060 |
Why?
|
| Anticholesteremic Agents | 1 | 2012 | 970 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 22352 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 5795 | 0.060 |
Why?
|
| Anesthesiology | 1 | 2015 | 1137 | 0.060 |
Why?
|
| International Cooperation | 1 | 2011 | 1434 | 0.060 |
Why?
|
| Registries | 3 | 2019 | 8351 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2011 | 5022 | 0.060 |
Why?
|
| Autistic Disorder | 1 | 1994 | 1238 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 1999 | 1525 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 2902 | 0.060 |
Why?
|
| Fluocinolone Acetonide | 1 | 2004 | 38 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 4114 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2024 | 149 | 0.060 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 88 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 265 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3425 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2023 | 12791 | 0.050 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 758 | 0.050 |
Why?
|
| Sleep | 1 | 2019 | 4815 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 2 | 2021 | 1365 | 0.050 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2005 | 283 | 0.050 |
Why?
|
| Liver | 3 | 2024 | 7571 | 0.050 |
Why?
|
| Agranulocytosis | 1 | 1983 | 98 | 0.050 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 1704 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 703 | 0.050 |
Why?
|
| Latin America | 1 | 2024 | 416 | 0.050 |
Why?
|
| Employment | 1 | 2009 | 1110 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 781 | 0.050 |
Why?
|
| Azathioprine | 2 | 1996 | 354 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2005 | 471 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2020 | 4522 | 0.050 |
Why?
|
| Statistics, Nonparametric | 3 | 2003 | 2846 | 0.050 |
Why?
|
| Hemochromatosis | 1 | 2004 | 175 | 0.050 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 8717 | 0.050 |
Why?
|
| HIV Infections | 2 | 2023 | 17536 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2007 | 554 | 0.050 |
Why?
|
| Oximetry | 2 | 2016 | 461 | 0.050 |
Why?
|
| Lectins | 1 | 2024 | 490 | 0.050 |
Why?
|
| Pulmonary Alveoli | 2 | 2017 | 665 | 0.050 |
Why?
|
| K562 Cells | 1 | 2024 | 645 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 4282 | 0.050 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1983 | 175 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2024 | 246 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 1245 | 0.050 |
Why?
|
| Physics | 1 | 2022 | 92 | 0.050 |
Why?
|
| Bone Density | 1 | 2015 | 3491 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5368 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 2 | 2018 | 1001 | 0.050 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2021 | 49 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2004 | 361 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 2006 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 581 | 0.050 |
Why?
|
| Loss of Heterozygosity | 1 | 2024 | 663 | 0.050 |
Why?
|
| Neoplasms | 4 | 2021 | 22350 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2013 | 175 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1071 | 0.050 |
Why?
|
| Dust | 2 | 2013 | 490 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2021 | 14471 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2024 | 921 | 0.050 |
Why?
|
| Tibia | 1 | 2007 | 1071 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2021 | 125 | 0.050 |
Why?
|
| Pregnancy | 5 | 2023 | 30237 | 0.050 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2020 | 30 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 42 | 0.050 |
Why?
|
| Myosins | 1 | 2022 | 407 | 0.050 |
Why?
|
| Lymphopenia | 1 | 1983 | 299 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 1707 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 1742 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 562 | 0.040 |
Why?
|
| Residual Volume | 2 | 2011 | 40 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2007 | 1362 | 0.040 |
Why?
|
| Pancreatic Elastase | 2 | 1992 | 124 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11651 | 0.040 |
Why?
|
| Polyadenylation | 1 | 2021 | 114 | 0.040 |
Why?
|
| Lead Poisoning | 1 | 2003 | 318 | 0.040 |
Why?
|
| Forced Expiratory Flow Rates | 2 | 2010 | 76 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
| Financing, Government | 1 | 2024 | 473 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2003 | 625 | 0.040 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 68 | 0.040 |
Why?
|
| Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
| Chronic Disease | 5 | 2019 | 9357 | 0.040 |
Why?
|
| Genes, Switch | 1 | 2020 | 48 | 0.040 |
Why?
|
| TATA Box Binding Protein-Like Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
| Observation | 2 | 2012 | 310 | 0.040 |
Why?
|
| Species Specificity | 1 | 2004 | 2413 | 0.040 |
Why?
|
| Risk | 3 | 2016 | 9602 | 0.040 |
Why?
|
| RNA-Binding Proteins | 2 | 2020 | 1884 | 0.040 |
Why?
|
| Bronchospirometry | 2 | 2011 | 10 | 0.040 |
Why?
|
| Pliability | 1 | 2019 | 57 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 5182 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 266 | 0.040 |
Why?
|
| beta Karyopherins | 1 | 2019 | 46 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 1659 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 32 | 0.040 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 1999 | 24 | 0.040 |
Why?
|
| Arylsulfotransferase | 1 | 2019 | 27 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2019 | 30 | 0.040 |
Why?
|
| rab4 GTP-Binding Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2019 | 120 | 0.040 |
Why?
|
| Steroidogenic Factor 1 | 1 | 1999 | 45 | 0.040 |
Why?
|
| Propensity Score | 2 | 2019 | 1972 | 0.040 |
Why?
|
| Eczema | 1 | 2002 | 244 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 220 | 0.040 |
Why?
|
| Air | 1 | 2020 | 182 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2010 | 26389 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2021 | 332 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2000 | 368 | 0.040 |
Why?
|
| Leukotriene Antagonists | 1 | 2000 | 124 | 0.040 |
Why?
|
| Interleukin-8 | 2 | 2012 | 702 | 0.040 |
Why?
|
| X Chromosome | 1 | 2023 | 819 | 0.040 |
Why?
|
| Salicylates | 2 | 1991 | 127 | 0.040 |
Why?
|
| Exoribonucleases | 1 | 2019 | 88 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2004 | 606 | 0.040 |
Why?
|
| England | 1 | 2020 | 533 | 0.040 |
Why?
|
| Granulosa Cells | 1 | 1999 | 120 | 0.040 |
Why?
|
| Organ Size | 2 | 2016 | 2261 | 0.040 |
Why?
|
| Prednisone | 3 | 2012 | 1566 | 0.040 |
Why?
|
| Hypersensitivity | 2 | 2012 | 1169 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3446 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 1999 | 143 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 2 | 1991 | 340 | 0.040 |
Why?
|
| Polymyositis | 1 | 1999 | 75 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2002 | 762 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 2000 | 359 | 0.040 |
Why?
|
| Telomere-Binding Proteins | 1 | 2019 | 122 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2003 | 619 | 0.040 |
Why?
|
| GATA4 Transcription Factor | 1 | 1999 | 125 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2019 | 2921 | 0.040 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1998 | 72 | 0.040 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 10264 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 6512 | 0.040 |
Why?
|
| Sjogren's Syndrome | 1 | 2000 | 240 | 0.040 |
Why?
|
| Africa | 1 | 2020 | 726 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 30 | 0.040 |
Why?
|
| Macrophages | 2 | 2024 | 5783 | 0.040 |
Why?
|
| Fibromuscular Dysplasia | 1 | 1998 | 55 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 353 | 0.040 |
Why?
|
| Neutropenia | 1 | 1983 | 894 | 0.040 |
Why?
|
| Massachusetts | 2 | 2009 | 8891 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1999 | 287 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 11061 | 0.040 |
Why?
|
| Tidal Volume | 2 | 2011 | 519 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2014 | 2274 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2021 | 560 | 0.040 |
Why?
|
| Environmental Pollutants | 1 | 2007 | 1294 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2007 | 1285 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 1459 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 740 | 0.040 |
Why?
|
| Iceland | 1 | 2017 | 183 | 0.040 |
Why?
|
| Germ Cells | 1 | 2021 | 645 | 0.040 |
Why?
|
| Xenobiotics | 1 | 2017 | 71 | 0.040 |
Why?
|
| Lipoxygenase | 1 | 1997 | 72 | 0.040 |
Why?
|
| Connective Tissue Diseases | 1 | 2000 | 285 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2023 | 1080 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10445 | 0.030 |
Why?
|
| Brazil | 1 | 2021 | 1249 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1999 | 731 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2023 | 871 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3250 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2024 | 1827 | 0.030 |
Why?
|
| Takayasu Arteritis | 1 | 1998 | 106 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2021 | 1716 | 0.030 |
Why?
|
| Oocytes | 1 | 2021 | 1168 | 0.030 |
Why?
|
| Benchmarking | 1 | 2023 | 1056 | 0.030 |
Why?
|
| Harm Reduction | 1 | 2017 | 143 | 0.030 |
Why?
|
| Lung Compliance | 1 | 2016 | 207 | 0.030 |
Why?
|
| Canada | 2 | 2013 | 2126 | 0.030 |
Why?
|
| Myasthenia Gravis | 1 | 1999 | 214 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5887 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2019 | 566 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 1677 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 2024 | 1456 | 0.030 |
Why?
|
| Netherlands | 2 | 2016 | 2277 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 787 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3420 | 0.030 |
Why?
|
| Double-Blind Method | 5 | 2012 | 12430 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 1078 | 0.030 |
Why?
|
| Proteins | 1 | 2010 | 6002 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2016 | 81 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 661 | 0.030 |
Why?
|
| Acetylation | 1 | 2018 | 1054 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2023 | 1343 | 0.030 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 8045 | 0.030 |
Why?
|
| Genes | 1 | 1999 | 1824 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3139 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2016 | 188 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2016 | 1494 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 7431 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1999 | 1155 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3459 | 0.030 |
Why?
|
| Anthropometry | 1 | 2020 | 1336 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 17088 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 4168 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 1044 | 0.030 |
Why?
|
| Aortography | 2 | 2012 | 423 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 7119 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2016 | 262 | 0.030 |
Why?
|
| Iron, Dietary | 1 | 2016 | 148 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1252 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 293 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1999 | 857 | 0.030 |
Why?
|
| Methicillin | 1 | 2014 | 62 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2021 | 1246 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2000 | 1250 | 0.030 |
Why?
|
| snRNP Core Proteins | 1 | 2014 | 21 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2015 | 5943 | 0.030 |
Why?
|
| Mannosidases | 1 | 2014 | 21 | 0.030 |
Why?
|
| alpha-Mannosidase | 1 | 2014 | 19 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 578 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2023 | 2867 | 0.030 |
Why?
|
| Antioxidants | 1 | 2002 | 1671 | 0.030 |
Why?
|
| Acute Disease | 3 | 2014 | 7241 | 0.030 |
Why?
|
| DNA Replication | 1 | 2021 | 1426 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 319 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1086 | 0.030 |
Why?
|
| Rhinitis | 1 | 2002 | 753 | 0.030 |
Why?
|
| Immediate-Early Proteins | 1 | 1997 | 444 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2006 | 766 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1994 | 114 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 229 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 684 | 0.030 |
Why?
|
| Education | 2 | 2012 | 531 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 630 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1998 | 1168 | 0.030 |
Why?
|
| Receptors, Estradiol | 1 | 2013 | 18 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 2016 | 381 | 0.030 |
Why?
|
| Lysine | 1 | 2018 | 997 | 0.030 |
Why?
|
| Methacholine Chloride | 2 | 2006 | 219 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2023 | 2590 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 589 | 0.030 |
Why?
|
| Epithelium | 1 | 2018 | 1606 | 0.030 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 1994 | 69 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 1474 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 21162 | 0.030 |
Why?
|
| Spain | 1 | 2015 | 483 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2018 | 639 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2840 | 0.030 |
Why?
|
| Texas | 1 | 2014 | 410 | 0.030 |
Why?
|
| Adiponectin | 1 | 2019 | 1121 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2001 | 2741 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 72 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 874 | 0.030 |
Why?
|
| Inhalation | 1 | 2013 | 142 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 412 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2001 | 1432 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1010 | 0.030 |
Why?
|
| Thiolester Hydrolases | 1 | 2014 | 91 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2017 | 791 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 724 | 0.030 |
Why?
|
| Scleroderma, Localized | 1 | 1994 | 85 | 0.030 |
Why?
|
| RNA Helicases | 1 | 2014 | 144 | 0.030 |
Why?
|
| Workflow | 1 | 2018 | 859 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2013 | 125 | 0.030 |
Why?
|
| Cyclophosphamide | 2 | 1996 | 2234 | 0.030 |
Why?
|
| Exhalation | 1 | 2013 | 185 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 2931 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2014 | 168 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 1647 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1520 | 0.030 |
Why?
|
| Fibrinopeptide A | 1 | 1992 | 43 | 0.030 |
Why?
|
| Trypsinogen | 1 | 1992 | 84 | 0.020 |
Why?
|
| Scopolamine Derivatives | 1 | 2012 | 23 | 0.020 |
Why?
|
| Heart Failure | 1 | 2016 | 11882 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 247 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1491 | 0.020 |
Why?
|
| Metabolome | 1 | 2019 | 1009 | 0.020 |
Why?
|
| Recurrence | 2 | 2016 | 8507 | 0.020 |
Why?
|
| Mites | 2 | 2002 | 46 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 513 | 0.020 |
Why?
|
| Demography | 1 | 2017 | 1641 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2012 | 286 | 0.020 |
Why?
|
| Thromboembolism | 1 | 1998 | 1003 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2014 | 392 | 0.020 |
Why?
|
| Theophylline | 1 | 2012 | 133 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2012 | 275 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2000 | 2141 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 939 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1973 | 479 | 0.020 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2003 | 197 | 0.020 |
Why?
|
| Models, Animal | 1 | 2018 | 2121 | 0.020 |
Why?
|
| Body Weight | 2 | 2013 | 4626 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2467 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 2093 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2014 | 369 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2014 | 592 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2004 | 243 | 0.020 |
Why?
|
| Maximal Expiratory Flow Rate | 1 | 1990 | 42 | 0.020 |
Why?
|
| Asia | 1 | 2013 | 629 | 0.020 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2012 | 138 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 461 | 0.020 |
Why?
|
| Lung Injury | 1 | 2016 | 432 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 227 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2015 | 1587 | 0.020 |
Why?
|
| Overweight | 1 | 2022 | 2446 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 1994 | 380 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 1814 | 0.020 |
Why?
|
| Cystitis | 1 | 1991 | 96 | 0.020 |
Why?
|
| Bleomycin | 1 | 2012 | 492 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 382 | 0.020 |
Why?
|
| Helicobacter Infections | 1 | 1994 | 390 | 0.020 |
Why?
|
| Bronchioles | 1 | 2010 | 25 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 1638 | 0.020 |
Why?
|
| Binding Sites | 1 | 1999 | 6012 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2011 | 381 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 707 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 887 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2014 | 470 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 6020 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2011 | 267 | 0.020 |
Why?
|
| Rats | 2 | 2013 | 23717 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2534 | 0.020 |
Why?
|
| Syndrome | 1 | 1996 | 3271 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 10745 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1999 | 2430 | 0.020 |
Why?
|
| Prednisolone | 1 | 2011 | 326 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1969 | 0.020 |
Why?
|
| Missouri | 1 | 1989 | 113 | 0.020 |
Why?
|
| Methotrexate | 1 | 1996 | 1719 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 755 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2017 | 2926 | 0.020 |
Why?
|
| Colonic Diseases | 1 | 1991 | 204 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1994 | 1617 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5306 | 0.020 |
Why?
|
| Untranslated Regions | 1 | 2008 | 30 | 0.020 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1989 | 112 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1973 | 548 | 0.020 |
Why?
|
| Intestinal Perforation | 1 | 1991 | 254 | 0.020 |
Why?
|
| Emotions | 1 | 2001 | 2758 | 0.020 |
Why?
|
| Toll-Like Receptors | 2 | 2002 | 582 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Phantoms, Imaging | 2 | 2009 | 2474 | 0.020 |
Why?
|
| Arthritis | 1 | 1994 | 684 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 1994 | 665 | 0.020 |
Why?
|
| Online Systems | 1 | 2009 | 181 | 0.020 |
Why?
|
| Twins | 1 | 2010 | 341 | 0.020 |
Why?
|
| Cathepsins | 1 | 1989 | 243 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 2629 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 776 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2009 | 277 | 0.020 |
Why?
|
| Health Services | 1 | 2013 | 755 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 1996 | 1008 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1994 | 1477 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 2586 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 1991 | 358 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1150 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 1754 | 0.020 |
Why?
|
| Receptors, Phencyclidine | 1 | 1987 | 13 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2024 | 8066 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8106 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1331 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2013 | 2628 | 0.020 |
Why?
|
| Vehicle Emissions | 1 | 2013 | 651 | 0.020 |
Why?
|
| Histones | 1 | 2018 | 2593 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 777 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3601 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1991 | 675 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1756 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 2470 | 0.020 |
Why?
|
| Blood Donors | 1 | 1989 | 344 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2010 | 642 | 0.020 |
Why?
|
| tau Proteins | 1 | 2018 | 2107 | 0.020 |
Why?
|
| Metagenomics | 1 | 2011 | 473 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 1319 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 1145 | 0.020 |
Why?
|
| Sweden | 1 | 2010 | 1382 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 1987 | 231 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2000 | 3715 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 987 | 0.020 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2006 | 77 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4410 | 0.020 |
Why?
|
| Breath Tests | 1 | 2008 | 297 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2013 | 939 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2006 | 127 | 0.020 |
Why?
|
| Korea | 1 | 2006 | 97 | 0.020 |
Why?
|
| Outpatients | 1 | 2014 | 1596 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2013 | 1319 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 4970 | 0.020 |
Why?
|
| Neutrophils | 2 | 2017 | 3782 | 0.020 |
Why?
|
| Cell Division | 1 | 1994 | 4474 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 2903 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 2493 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1987 | 1141 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1991 | 1392 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 1659 | 0.020 |
Why?
|
| Chemokine CCL11 | 1 | 2006 | 127 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 1999 | 3079 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2010 | 677 | 0.020 |
Why?
|
| Tropoelastin | 1 | 2005 | 28 | 0.020 |
Why?
|
| Lipoprotein(a) | 1 | 2010 | 489 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1964 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 3531 | 0.020 |
Why?
|
| Arthralgia | 1 | 2009 | 459 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5890 | 0.020 |
Why?
|
| Health Surveys | 1 | 2015 | 4055 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3607 | 0.010 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2004 | 29 | 0.010 |
Why?
|
| Fibromyalgia | 1 | 2009 | 407 | 0.010 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2004 | 12 | 0.010 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2004 | 58 | 0.010 |
Why?
|
| Quebec | 1 | 2004 | 140 | 0.010 |
Why?
|
| Biometry | 1 | 2007 | 571 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2005 | 10384 | 0.010 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 1983 | 12 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2012 | 4018 | 0.010 |
Why?
|
| Body Burden | 1 | 2004 | 156 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1990 | 2221 | 0.010 |
Why?
|
| Hypertension | 2 | 2014 | 8616 | 0.010 |
Why?
|
| Puerto Rico | 1 | 2004 | 380 | 0.010 |
Why?
|
| Apolipoprotein E3 | 1 | 2003 | 105 | 0.010 |
Why?
|
| Apolipoprotein E2 | 1 | 2003 | 134 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1994 | 5503 | 0.010 |
Why?
|
| Triglycerides | 1 | 2010 | 2441 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2823 | 0.010 |
Why?
|
| Fatigue | 1 | 2009 | 1555 | 0.010 |
Why?
|
| Mexico | 1 | 2004 | 770 | 0.010 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 345 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2004 | 271 | 0.010 |
Why?
|
| Immune Sera | 2 | 1992 | 605 | 0.010 |
Why?
|
| Air Pollution | 1 | 1996 | 2391 | 0.010 |
Why?
|
| Alternaria | 1 | 2002 | 41 | 0.010 |
Why?
|
| Cockroaches | 1 | 2002 | 92 | 0.010 |
Why?
|
| Glucose | 1 | 1994 | 4340 | 0.010 |
Why?
|
| Pollen | 1 | 2002 | 80 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 515 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 640 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2903 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 966 | 0.010 |
Why?
|
| Vasculitis | 2 | 1999 | 528 | 0.010 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2001 | 143 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1996 | 4855 | 0.010 |
Why?
|
| Skin | 1 | 2014 | 4499 | 0.010 |
Why?
|
| Lipids | 1 | 2012 | 3319 | 0.010 |
Why?
|
| Dinucleotide Repeats | 1 | 2000 | 28 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1994 | 4784 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2002 | 517 | 0.010 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 2000 | 23 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2013 | 2817 | 0.010 |
Why?
|
| Monocytes | 1 | 1989 | 2600 | 0.010 |
Why?
|
| Face | 1 | 2006 | 1029 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 2007 | 4559 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 3815 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2003 | 709 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2002 | 588 | 0.010 |
Why?
|
| Diagnosis, Differential | 3 | 1998 | 12985 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3093 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2010 | 3957 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2000 | 301 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2000 | 309 | 0.010 |
Why?
|
| Child Welfare | 1 | 2002 | 521 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2009 | 3561 | 0.010 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1997 | 74 | 0.010 |
Why?
|
| Codon, Initiator | 1 | 1997 | 50 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4913 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1997 | 133 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1997 | 325 | 0.010 |
Why?
|
| Anemia, Aplastic | 1 | 1999 | 231 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2003 | 1367 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2010 | 2931 | 0.010 |
Why?
|
| Aortic Coarctation | 1 | 1998 | 278 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4853 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 7841 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5536 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1998 | 627 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1999 | 792 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8728 | 0.010 |
Why?
|
| China | 1 | 2000 | 2383 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1998 | 591 | 0.010 |
Why?
|
| Melanoma | 1 | 1973 | 5700 | 0.010 |
Why?
|
| Leg Length Inequality | 1 | 1994 | 56 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 13411 | 0.010 |
Why?
|
| Mass Screening | 1 | 1989 | 5454 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1973 | 317 | 0.010 |
Why?
|
| DNA Primers | 1 | 1997 | 2826 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 9244 | 0.010 |
Why?
|
| Carboxypeptidases A | 1 | 1992 | 27 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 8088 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1997 | 1525 | 0.010 |
Why?
|
| Fever | 2 | 1991 | 1607 | 0.010 |
Why?
|
| Carboxypeptidases | 1 | 1992 | 121 | 0.010 |
Why?
|
| Plasmids | 1 | 1997 | 2268 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1998 | 1110 | 0.010 |
Why?
|
| Leukocyte Elastase | 1 | 1992 | 113 | 0.010 |
Why?
|
| Ultrafiltration | 1 | 1991 | 47 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2003 | 2538 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 1999 | 2730 | 0.010 |
Why?
|
| Cyanosis | 1 | 1991 | 82 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1994 | 1180 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1994 | 992 | 0.010 |
Why?
|
| Thrombocytosis | 1 | 1991 | 88 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13643 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1999 | 4860 | 0.010 |
Why?
|
| Cathepsin G | 1 | 1989 | 41 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1991 | 544 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1989 | 276 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 1528 | 0.000 |
Why?
|
| Drug Hypersensitivity | 1 | 1997 | 903 | 0.000 |
Why?
|
| Thyroidectomy | 1 | 1994 | 912 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1989 | 563 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1988 | 361 | 0.000 |
Why?
|
| Biological Availability | 1 | 1988 | 387 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1973 | 1560 | 0.000 |
Why?
|
| Rabbits | 1 | 1973 | 4752 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1989 | 1697 | 0.000 |
Why?
|
| Stents | 1 | 1998 | 3193 | 0.000 |
Why?
|
| Fibronectins | 1 | 1989 | 722 | 0.000 |
Why?
|
| Brain | 1 | 2012 | 27159 | 0.000 |
Why?
|
| Serine Endopeptidases | 1 | 1989 | 1027 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1991 | 1276 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1973 | 1434 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1973 | 4891 | 0.000 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1994 | 2429 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1991 | 3100 | 0.000 |
Why?
|
| Insulin | 1 | 1994 | 6608 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1994 | 6422 | 0.000 |
Why?
|
| Protein Binding | 1 | 1991 | 9320 | 0.000 |
Why?
|
| Kidney | 1 | 1988 | 7074 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1994 | 36567 | 0.000 |
Why?
|